多模态影像对前列腺癌检测与局部分期的头对头比较:全mount病理参考
该回顾性研究以全mount病理为参考,头对头比较微超声、多参数磁共振和PSMA PET/CT检测临床显著前列腺癌及前列腺外侵犯的表现。结果显示三种模态在指标病灶和csPCa检测上无统计学显著差异,但mpMRI对csPCa的阳性预测值更高,且mpMRI在分区水平对csPCa和EPE的AUC最高。约15-18%的csPCa病灶被各模态遗漏,均为非指标Grade Group 2且Gleason 4模式≤20%。
要点
- 微超声与mpMRI、PSMA PET/CT在指标病灶和csPCa检测上无统计学显著差异。
- mpMRI对csPCa的阳性预测值高于微超声(0.91 vs 0.77,p=0.03)。
- 各模态遗漏15-18%的csPCa病灶,均为非指标Grade Group 2且Gleason 4模式≤20%。
核心结论
- 微超声与mpMRI和PSMA PET/CT在检测指标病灶和csPCa上无统计学显著差异,支持其在资源有限或MRI禁忌场景中的潜在补充作用。
主要发现
- 指标病灶检测率:微超声0.90、mpMRI 0.94、PSMA PET/CT 0.93,无统计学显著差异。
- csPCa检测率:微超声0.71、mpMRI 0.78、PSMA PET/CT 0.72,无统计学显著差异。
- mpMRI对csPCa的阳性预测值高于微超声(0.91 vs 0.77,p=0.03)。
- mpMRI在分区水平对csPCa和EPE的AUC最高,分别为0.73和0.88。
- 各模态遗漏15-18%的csPCa病灶,均为非指标Grade Group 2且Gleason 4模式≤20%。
临床怎么用
- 微超声可作为资源有限或MRI禁忌情况下的潜在补充影像手段。
- mpMRI对csPCa的阳性预测值更高,在条件允许时仍应优先考虑。
局限性
- 单中心回顾性设计。
- 研究可能效力不足,无法检测微小差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate detection and local staging of prostate cancer (PCa) remain critical for treatment planning, yet head-to-head multimodal imaging comparisons remain limited. OBJECTIVE: This study compared microultrasound (microUS), multiparametric magnetic resonance imaging (mpMRI), and prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) for detecting clinically significant PCa (csPCa) and extraprostatic extension (EPE), using whole-mount histopathology (WMHP) as the reference standard. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study included patients who underwent microUS and mpMRI followed by radical prostatectomy between January 2023 and October 2024. A subset also underwent PSMA PET/CT. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Detection of csPCa and EPE was assessed at the lesion and sector levels using WMHP as a reference. Detection rates and positive predictive values (PPVs) were compared using McNemar and chi-square tests, while sector-level area under the receiver operating characteristic curves (AUCs) were compared using the DeLong test. RESULTS AND LIMITATIONS: No statistically significant differences were observed between microUS and mpMRI or PSMA PET/CT for index lesion detection (0.90, 0.94, and 0.93, respectively) or csPCa detection (0.71, 0.78, and 0.72, respectively), although the study may have been underpowered to detect small differences. mpMRI had higher PPVs for csPCa than microUS (0.91 vs 0.77, p = 0.03). mpMRI achieved the highest sector-level AUCs for csPCa (0.73) and EPE (0.88). Across modalities, 15-18% of csPCa lesions were missed, which were non-index Grade Group 2 with Gleason pattern 4 ≤20%. The study is limited by its single-center retrospective design. CONCLUSIONS: MicroUS showed no statistically significant differences compared with mpMRI and PSMA PET/CT for detecting index and csPCa lesions, supporting a potential complementary role in resource-limited or MRI-contraindicated settings.
引用
- Miao Q, Sisk A, Sonni I, et al. Head-to-head Comparison of Multimodal Imaging for Prostate Cancer Detection and Local Staging with Whole-mount Histopathology Reference. Eur Urol Oncol. 2026. PMID: 42276879. doi:10.1016/j.euo.2026.05.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。